Ease the burden of Alpha-1 therapy for your patients.
Low infusion volumes allow for treatment in as little as 15 minutes*
ZEMAIRA can be stored safely at room temperature
Mix2Vial® Transfer Set enables rapid reconstitution
*Average infusion time is based on an infusion rate of 0.08 mL/kg/min for a 75kg (165lb) patient. Individual experiences may vary.
A 165-pound patient will require 90 mL of solutionCheck out the dosing calculator
To use the dosing calculator, please agree to the end user license agreement below.
END USER LICENSE AGREEMENT FOR CSL BEHRING LLC ZEMAIRA DOSAGE CALCULATOR
CSL does not collect personal information about you when you use this Calculator. If you have any question regarding the use of your non-personal information resulting from your use of the Calculator, please contact us at email@example.com.
Please agree to the end user license agreement before continuing
Enter patient's weight:
Based on a weight of 0 lb/0 kg, the recommended dose of ZEMAIRA for your patient is:
ZEMAIRA undergoes rigorous manufacturing processes to produce a highly purified augmentation therapy approved by the FDA.
While all efforts are made to prevent the transmission of infectious agents and viruses, the risk of transmission cannot be completely eliminated.
Dotted line represents an A1AT level of 11 µM, a threshold presumed to provide therapeutically relevant anti-neutrophil elastase protection.
†Clinical data demonstrating the long-term effects of chronic augmentation therapy with ZEMAIRA are not available. The effect of augmentation therapy with ZEMAIRA or any alpha1-proteinase inhibitor (A1-PI) product on pulmonary exacerbations and the progression of emphysema in A1AT deficiency have not been demonstrated in randomized, controlled clinical studies.
The most common adverse reactions occurring in at least 5% of subjects receiving ZEMAIRA in all pre-licensure clinical trials were headache, sinusitis, upper respiratory infection, bronchitis, asthenia, cough increased, fever, injection site hemorrhage, rhinitis, sore throat, and vasodilation.
CSL Behring has a long history of innovation and dedication to the Alpha-1 community. Learn more about how the ZEMAIRA Support Program keeps your Alpha-1 patients covered.